ponatinib,blinatumomab
incyte,amgen,otsuka,takeda,astellas pharmaceuticals
['leusm', 'ponatinib', 'blinatumomab']
ponatinib plus blinatumomab for patients with philadelphia chromosome positive all #leusm #hematology #immunotherapy #eha2022
News and views from the world of clinical oncology and hematology